|
|
 |
|
| Breast Cancer Highlight |
| 1. A BRCA2 founder mutation and seven novel deleterious BRCA mutations in southern Chinese women with breast and ovarian cancer. [PubMed] |
| 2. A novel de novo BRCA1 mutation in a Chinese woman with early onset breast cancer. [PubMed] |
| 3. Characterization of the pathogenic mechanism of a novel BRCA2 variant in a Chinese family. [PubMed] |
| 4. Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. [PubMed] |
| 5. ENIGMA--evidence-based network for the interpretation of germline mutant alleles: an international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genes. [PubMed] |
| 6. High-resolution melting analysis for rapid screening of BRCA2 founder mutations in Southern Chinese breast cancer patients. [PubMed] |
| 7. Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis. [PubMed] |
| 8. MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast Cancer. [PubMed] |
| 9. Novel BRCA1 and BRCA2 genomic rearrangements in Southern Chinese breast/ovarian cancer patients. [PubMed] |
| 10. Quantitative analysis and diagnostic significance of methylated SLC19A3 DNA in the plasma of breast and gastric cancer patients. [PubMed] |
| Cancer Biomarkers |
| 11. Amplification, mutation and loss of heterozygosity of the EGFR gene in metastatic lung cancer.[PubMed] |
| 12. Detection of KRAS mutations in colorectal cancer by high-resolution melting analysis. [PubMed] |
| 13. EGFR gene mutation study in cytology specimens. [PubMed] |
| 14. Synchronous primary lung cancer and epidermal growth factor receptor mutation.[PubMed] |
| 15. Evaluation of two real-time PCR assays for in-vitro diagnostic use in the rapid and multiplex detection of EGFR gene mutations in NSCLC. In Press |
| Hematopathology |
| 16. A novel beta-delta globin gene fusion, anti-Lepore Hong Kong, leads to overexpression of delta globin chain and a mild thalassaemia intermedia phenotype when co-inherited with beta(0)-thalassaemia. [PubMed] |
| 17. Burkitt lymphoma presenting as posterior reversible encephalopathy syndrome secondary to hypercalcaemia. [PubMed] |
| 18. Combined factors V and VIII deficiency (F5F8D) in a Chinese family due to compound heterozygosity for nonsense mutations of the LMAN1 gene. [PubMed] |
| 19. Detection and characterisation of beta-globin gene cluster deletions in Chinese using multiplex ligation-dependent probe amplification. [PubMed] |
| 20. Detection of FIP1L1-PDGFRA fusion by FISH. [PubMed] |
| 21. Hematologic and genetic characterization of an MYH9-related disorder in a Chinese family. [PubMed] |
| 22. JAK2 V617F due to a novel TGCT mutation at nucleotides 1848-1849: diagnostic implication. [PubMed] |
| 23. The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of beta-thalassaemia. [PubMed] |
| Infectious Diseases |
| 24. A crucial role of macrophages in the immune responses to oral DNA vaccination against hepatitis B virus in a murine model. [PubMed] |
| 25. Antibiotics modulate vaccine-induced humoral immune response. [PubMed] |
| 26. Ciprofloxacin decreased polyoma BK virus load in patients who underwent allogeneic hematopoietic stem cell transplantation. [PubMed] |
| 27. Comparison of two automated DNA amplification systems with a manual one-tube nested PCR assay for diagnosis of pulmonary tuberculosis. [PubMed] |
| 28. DNA immunization using a secreted cell wall antigen Mp1p is protective against Penicillium marneffei infection. [PubMed] |
| 29. Enhancement by ampicillin of antibody responses induced by a protein antigen and a DNA vaccine carried by live-attenuated Salmonella enterica serovar Typhi. [PubMed] |
| 30. Kocuria kristinae infection associated with acute cholecystitis. [PubMed] |
| 31. Plasma Epstein-Barr virus (EBV) DNA: role as a screening test for nasopharyngeal carcinoma (NPC)?[PubMed] |
| 32. Rapid quantification of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. [PubMed] |
| 33. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. [PubMed] |
| 34. SARS coronavirus spike polypeptide DNA vaccine priming with recombinant spike polypeptide from Escherichia coli as booster induces high titer of neutralizing antibody against SARS coronavirus.[PubMed] |
| 35. Three cases of severe invasive infections caused by Campylobacter rectus and first report of fatal C. rectus infection. [PubMed] |
| 36. Unique immunogenicity of hepatitis B virus DNA vaccine presented by live-attenuated Salmonella typhimurium. [PubMed] |
|
|
|
|
|
|
|
|
Shipping & Billing Information
|
Non-disclosure and Complaints
All data/information generated from within/related to HKMPDC and our customers are treated in strict confidence in accordance with the Personal Data (Privacy) Ordinance of Hong Kong. If you have a complaint, please contact us at the (852) 2986 1213 or email us at contact@hk-mpdc.com. All communications with HKMPDC would be dealt with in strict confidence.
Notice of Privacy Practices
This notice describes how medical information about you may be used and disclosed.
Personal health information or related information released to HKMPDC relating to the services requested may be subjected to re-disclosure by HKMPDC to health care providers, such as doctors, nurses, and others involved in the delivery of the services.
We may also disclose medical information about you to authorised public health or government officials for public health activities as required by law and accreditation body.
Copyright © 2013 香港分子病理檢驗中心 Hong Kong Molecular Pathology Diagnostic Centre Limited (HKMPDC). All Rights Reserved.
Information Updated 1 July, 2023.
|
|
|
|
